FundedIQ
Biotechnology

Delve Bio: Funding, Investors & Team (Oct 2026)

Delve Bio is a biotechnology business that provides molecular insights for patient precision care. Delve Bio is a biotechnology business that aims to give molecular insights for precision patient care.

www.delve.bio San Francisco, United States 1-10 employees
Total raised
$35.0M
Rounds
1
Latest
Series A
Jun 2023

Delve Bio has raised $35.0M across 1 funding round on record, the most recent a Series A of $35.0M announced in Jun 2023.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Delve Bio Company Profile and Key Stats

Total funding raised
$35.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$35.0M in Jun 2023
Employees
1-10
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jun 2023.

Delve Bio Funding Rounds

Date
Round
Amount
Series A
$35.0M

Delve Bio Founders and Leadership Team

Name
Role
Contact
Steve Miller
Founder
Locked

Contact details for the Delve Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Delve Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
8,591
$15M

Delve Bio's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Delve Bio in Biotechnology and San Francisco

Companies Similar to Delve Bio

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Delve Bio Funding FAQs

What does Delve Bio do?

Delve Bio is a biotechnology business that provides molecular insights for patient precision care. Delve Bio is a biotechnology business that aims to give molecular insights for precision patient care.

How much funding has Delve Bio raised?

Delve Bio has raised $35.0M across 1 round on record. The most recent is a Series A of $35.0M announced in Jun 2023.

When did Delve Bio last raise funding?

Delve Bio's most recent funding round on record is a Series A of $35.0M, announced in Jun 2023.

Who founded Delve Bio?

FundedIQ lists Steve Miller (Founder) at Delve Bio.

Where is Delve Bio headquartered?

Delve Bio is based in San Francisco, California, United States.

How many employees does Delve Bio have?

Delve Bio is in the 1-10 employee band.

How does Delve Bio's funding compare to other Biotechnology startups?

Delve Bio's latest round of $35.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Delve Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Delve Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.